3Lurie S, Piper I, Woliovitch Iet al. Age - related prevalence of sonographically confirmed uterine myomas [J].J Obstet Gynaecol, 2005, 25 (1): 42.
4Maruo T, Ohara N Wang J et al. Sex steroidal regulation of uterine leiomyenm growth and apoplosis [ J] . Hum Reprod Update, 2004, 10 (3) : 207.
二级参考文献7
1Welty FK. Cardiovascular disease and dyslipidemia in women [J]. Arch Intern Med, 2001,161 (4) : 514-522.
2Shlipak MG, Simon JA, Vittinghoff E, et al. Estrogen and progestin ( a), and the risk of recurrent coronary heart disease events after menopause [ J]. JAMA,2000, 283 : 1845-1852.
3Mosca L,Collins P,Herrington DM, et al. Hormone replacement therapy and cardiovascular disease : a statement for healthcare professionals from the American Heart Association [ J ]. Cireulation,2001,104:499-503.
4Jacque E, Garnet L,Marcia L,et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women [ J ]. JAMA,2002,288 (3) :1.
5Wakatsuki A, Okatani Y, Fukaya T, et al. Different effects of oral conjugated equine estrogen and transdermal estrogen replacement therapy on size and oxidative susceptibility of low density lipoprotein particles in postmenopausal women [ J ]. Circulation, 2002, 106 (14) : 1771-1776.
6Rajewska J, Rybakowski JK. Depression in premenopausal women:gonadal hormones and serotonergic system assessed by D-fenfluramine challenge test [ J ]. Prog Neuropsychopharmacol Biol Psychiatry, 2003,27(4) : 705-709.
1Lurie S,Piper I,Woliovitch I et al.Age-related prevalence of sonographically confirmed uterine myomas[J].J Obstet Gynecol,2005,25(1):42.
2Palomba S, Sena T, Noia R, et al. Transdermal hormone replacement therapy in postmenopausal women with uterine leiomyomas. Obstel Gynecol,2001,98(6) :1053-1054.